~~<i id='CEE41ADD6F'><strike id='CEE41ADD6F'><tt id='CEE41ADD6F'><pre id='CEE41ADD6F'></pre></tt></strike></i>~~

Home» explore» fashion

fashion

author：knowledge 2025-10-02 00:22:00 Page View：5465

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Severe heat forecast: Where scorching temperatures will persist over the next week
Next article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

comprehensive

At least 13 dead in Texas as scorching temps continue

1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

2023 Nobel Prize in Medicine goes to Karikó and Weissman

AssociatedPressLONDON—TwopioneersofmRNAresearch—thetechnologythathelpedtheworldtamethevirusbehindthe

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

RSV injection headlines need to be accurate for good uptake

STAT/AstraZenecaviaAPAstheoristsfromSamuelColeridgetoKennethBurkehavenoted,languageoftendoesourthink